The Two Major Structural Phosphoproteins (pp65 and pp150) of Human Cytomegalovirus and Their Antigenic Properties

References

1. Bernstein D. I., Garratty E., Lovett M. A., Bryson Y. J. 1985; Comparison of Western blot analysis to microneutralization for the detection of type-specific herpes simplex virus antibodies. Journal of Medical Virology 15:223–230
   [Google Scholar]
2. Bonner W. M., Laskey R. A. 1974; A film detection method for tritium-labeled proteins and nucleic acids in polyacrylamide gels. European Journal of Biochemistry 46:83–88
   [Google Scholar]
3. Britt W. J. 1984; Neutralizing antibodies detect a disulfide-linked glycoprotein complex within the envelope of human cytomegalovirus. Virology 135:369–378
   [Google Scholar]
4. Britt W. J., Auger D. 1985; Identification of a 65000 dalton virion envelope protein of human cytomegalovirus. Virus Research 4:31–36
   [Google Scholar]
5. Britt W. J., Auger D. 1986; Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus. Journal of Virology 58:185–191
   [Google Scholar]
6. Chou P. Y., Fasman G. D. 1974; Prediction of protein conformation. Biochemistry 13:222–245
   [Google Scholar]
7. Cremer N. E., Cossen C. K., Shell G. R., Pereira L. 1985; Antibody response to cytomegalovirus polypeptides captured by monoclonal antibodies on the solid phase in enzyme immunoassays. Journal of Clinical Microbiology 21:517–521
   [Google Scholar]
8. Davis M. G., Huang E.-S. 1985; Nucleotide sequence of a human cytomegalovirus DNA fragment encoding a 67-kilodalton phosphorylated viral protein. Journal of Virology 56:7–11
   [Google Scholar]
9. Eberle R., Mou S.-W. 1983; Relative titers of antibodies to individual polypeptide antigens of herpes simplex virus type 1 in human sera. Journal of Infectious Diseases 148:436–443
   [Google Scholar]
10. Farrar G. H., Oram J. D. 1984; Characterization of the human cytomegalovirus envelope glycoproteins. Journal of General Virology 65:1991–2001
    [Google Scholar]
11. Forman S. J., Zaia J. A., Clark B. R., Wright C. L., Mills B. J., Pottathil R., Racklin B. C., Gallagher M. T., Welte K., Blume K. G. 1985; A 64,000 dalton matrix protein of human cytomegalovirus induces in vitro immune responses similar to those of whole viral antigen. Journal of Immunology 134:3391–3395
    [Google Scholar]
12. Gibson W. 1983; Protein counterparts of human and simian cytomegaloviruses. Virology 128:391–406
    [Google Scholar]
13. Gibson W., Irmiere A. 1984; Selection of particles and proteins for use as human cytomegalovirus subunit vaccines. In Birth Defects (Original Articles Series) 20 pp. 305–324 Plotkin S. A., Michelson S., Pagano J. S. Edited by New York: Alan R. Liss;
    [Google Scholar]
14. Hopp T. P., Woods K. R. 1981; Prediction of protein antigenic determinants from amino acid sequences. Proceedings of the National Academy of Sciences, U.S.A 78:3824–3828
    [Google Scholar]
15. Irmiere A., Gibson W. 1983; Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus. Virology 130:118–133
    [Google Scholar]
16. Kahlon J., Lakeman F. D., Ackermann M., Whitley R. J. 1986; Human antibody response to herpes simplex virus-specific polypeptides after primary and recurrent infection. Journal of Clinical Microbiology 23:725–730
    [Google Scholar]
17. Kim K. s., Sapienza V. J., Carp R. I., Moon H. M. 1976; Analysis of structural polypeptides of purified human cytomegalovirus. Journal of Virology 20:604–611
    [Google Scholar]
18. Kim K. s., Sapienza V. J., Chen C.-M., Wisniewski H. 1983; Production and characterization of monoclonal antibodies specific for a glycosylated polypeptide of human cytomegalovirus. Journal of Clinical Microbiology 18:331–343
    [Google Scholar]
19. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature; London: 227680–685
    [Google Scholar]
20. Landini M. P., Re M. C., Mirolo G., Baldassarri B., La Placa M. 1985; Human immune response to cytomegalovirus structural polypeptides studied by immunoblotdng. Journal of Medical Virology 17:303–311
    [Google Scholar]
21. Landini M. P., Mirolo G., Coppolecchia P., Re M. C., La Placa M. 1986; Serum antibodies to individual cytomegalovirus structural polypeptides in renal transplant recipients during viral infection. Microbiology and Immunology 30:683–695
    [Google Scholar]
22. Mach M., Utz U., Fleckenstein B. 1986; Mapping of the major glycoprotein gene for human cytomegalovirus. Journal of General Virology 67:1461–1467
    [Google Scholar]
23. Mar E. C., Patel P. C., Huang E. s. 1981; Human cytomegalovirus-associated DNA polymerase and protein kinase activities. Journal of General Virology 57:149–156
    [Google Scholar]
24. Merril C. R., Goldmann D., Sedman S. A., Ebert M. H. 1981; Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins. Science 211:1437–1438
    [Google Scholar]
25. Nowak B., Gmeiner A., Sarnow P., Levine A. J., Fleckenstein B. 1984a; Physical mapping of human cytomegalovirus genes: identification of DNA sequences coding for a virion phosphoprotein of 71 kDa and a viral 65-kDa polypeptide. Virology 134:91–102
    [Google Scholar]
26. Nowak B., Sullivan C., Sarnow P., Thomas R., Bricout F., Nicolas J, Fleckenstein B., Levine A. J. 1984b; Characterization of monoclonal antibodies and polyclonal immune sera directed against human cytomegalovirus virion proteins. Virology 132:325–338
    [Google Scholar]
27. Pande H., Baak s. W., Riggs A. D., Clark B. R., Shively J. E., Zaia I. A. 1984; Cloning and physical mapping of a gene fragment coding for a 64-kilodalton major late antigen of human cytomegalovirus. Proceedings of the National Academy of Sciences, U.S.A 81:4965–4969
    [Google Scholar]
28. Pereira L., Hoffman M., Cremer N. 1982a; Electrophoretic analysis of polypeptides immune precipitated from cytomegalovirus-infected cell extracts by human sera. Infection and Immunity 36:933–942
    [Google Scholar]
29. Pereira L., Hoffman M., Gallo D., Cremer N. 1982b; Monoclonal antibodies to human cytomegalovirus: three surface membrane proteins with unique immunological and electrophoretic properties specify crossreactive determinants. Infection and Immunity 36:924–932
    [Google Scholar]
30. Pereira L., Stagno S., Hoffman M., Volanakis J. E. 1983; Cytomegalovirus-infected cell polypeptides immune-precipitated by sera from children with congenital and perinatal infections. Infection and Immunity 39:100–108
    [Google Scholar]
31. Pereira L., Hoffman M., Tatsuno M., Dondero D. 1984; Polymorphism of human cytomegalovirus glycoproteins characterized by monoclonal antibodies. Virology 139:73–86
    [Google Scholar]
32. Roby C., Gibson W. 1986; Characterization of phosphoproteins and protein kinase activity of virions, noninfectious enveloped particles, and dense bodies of human cytomegalovirus. Journal of Virology 59:714–727
    [Google Scholar]
33. Rüger B., Klages S., Walla B., Albrecht J., Fleckenstein B., Tomlinson P., Barrell B. 1987; Primary structure and transcription of the genes coding for the two virion phosphoproteins pp65 and pp71 of human cytomegalovirus. Journal of Virology in press
    [Google Scholar]
34. Schmitz H., Müller-Lantzsch N., Peteler G. 1980; Human immune response to proteins of cytomegalovirus. Intervirology 13:154–161
    [Google Scholar]
35. Stinski M. F. 1976; Human cytomegalovirus: glycoproteins associated with virions and dense bodies. Journal of Virology 19:594–609
    [Google Scholar]
36. Talbot P., Almeida J. D. 1977; Human cytomegalovirus: purification of enveloped virions and dense bodies. Journal of General Virology 36:345–349
    [Google Scholar]
37. Towbin H., Staehelin T., Gordon J. 1979; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences, U.S.A 76:4350–4354
    [Google Scholar]
38. Zaia A., Forman J., Ting Y.-P., Urbina E., Blume G. 1986; Polypeptide-specific antibody response to human cytomegalovirus after infection in bone marrow transplant recipients. Journal of Infectious Diseases 153:780–787
    [Google Scholar]